Technical sheets
Technical reference sheets
Fifteen of the most studied peptides, with mechanism of action, evidence and considerations — each labeled by its real level of evidence.
Semaglutida
GLP-1 receptor agonist
Long-acting GLP-1 agonist for glycemic and weight control.
View sheetTirzepatida
GIP/GLP-1 co-agonist (dual incretin)
Dual incretin agonist with marked metabolic and weight effect.
View sheetRetatrutida
GIP/GLP-1/glucagon triple agonist
Triple agonist in clinical development for obesity and metabolism.
View sheetCagrilintida
Long-acting amylin analogue
Amylin analogue that reinforces satiety; studied alone and combined.
View sheetBPC-157
Pentadecapeptide (sequence derived from a gastric protein)
Repair peptide with mostly preclinical evidence.
View sheetTB-500
Synthetic fragment related to thymosin β4
Fragment associated with cell migration and angiogenesis (proposed).
View sheetIpamorelina
Selective GH secretagogue (ghrelin receptor / GHS-R agonist)
Selective secretagogue that stimulates pulsatile GH release.
View sheetCJC-1295
Long-acting GHRH analogue
GHRH analogue that prolongs GH/IGF-1 stimulation.
View sheetTesamorelina
Stabilized GHRH analogue
GHRH analogue approved to reduce visceral fat in HIV lipodystrophy.
View sheetSermorelina
GHRH analogue (fragment 1-29)
GHRH fragment historically used in GH diagnosis.
View sheetGHK-Cu
Copper tripeptide (glycyl-histidyl-lysine copper complex)
Copper peptide studied in dermal remodeling and cosmetics.
View sheetPT-141 (Bremelanotida)
Melanocortin receptor agonist (MC4R)
Melanocortin agonist approved for hypoactive sexual desire.
View sheetMelanotan-2
Synthetic α-MSH analogue (non-selective melanocortin agonist)
Melanocortin analogue linked to melanogenesis; not approved.
View sheetSemax
Heptapeptide derived from ACTH (4-10)
Neuromodulator with mostly preclinical evidence outside Russia.
View sheetEpitalón
Tetrapeptide (Ala-Glu-Asp-Gly)
Tetrapeptide with longevity hypotheses and very limited evidence.
View sheetEducational reference sheet. It is not a recommendation to use, a clinical indication or a protocol. Many of these compounds are marketed for research use only and are not approved for human use. Always cross-check with the primary literature and the regulation in your country.